Applying stem cell technology for cardiovascular indications is not just an idea anymore.

CardioCell is currently in clinical trials using stem cells to develop “off-the-shelf” products for cardiovascular indication. The company is exploring unmet medical needs in:

For clinical trials, CardioCell is using cGMP allogeneic stem cells derived from the bone marrow of healthy volunteers.

These cells are manufactured in a licensed cGMP-compliant facility.